Anti-doping officers are happy: drug manufacturers cooperate with them

Today many drug manufacturers are ready to collaborate with anti-doping officials in their fight against usage of prohibited products in sports. It sounds strange but it is the reality. In fact, if you review the fate of EPO, you can understand why pharmaceutical companies agree to support efforts of anti-doping officials. EPO is actually an efficient remedy for treatment of anemia. Numerous individuals with anemia that have applied EPO have been treated. But what do you think while hearing about this preparation? Almost any individual associates this remedy only with doping in sports. This drug has been abused by the seven-time winner Lance Armstrong that has cheated the whole world. So, EPO is associated only with cheating, shame, etc. Looking at this case, drug manufacturers try to “defend” their medications from the similar fate. That’s why they work together with anti-doping agencies.
Although several pharmaceutical companies started to collaborate with anti-doping agencies long ago, sometimes there were some problems between them. Anti-doping agencies criticized certain pharmaceutical companies for their connections with doping.
Today relations between anti-doping officials and drug manufacturers are better. Drug manufacturers share detailed information about new medications with anti-doping agencies. It is precious information for development of detection tests for these medications. While anti-doping officers find out how drugs are manufactured, how they pass into body, how they work in the body, they can develop more effectual tests for these medications.
For example, the drug manufacturer Roche that elaborated the medicine CERA helped anti-doping officers to develop a detection test for it. Later other companies followed the example of Roche. The drug manufacturer GlaxoSmithKline went so far, as it sponsored an anti-doping lab during London Olympics.
While relations between anti-doping officials and huge drug manufacturers become closer, smaller drug manufacturers begin to cooperate with anti-doping agencies as well. While previously pharmaceutical companies haven’t wanted to discuss about their relations with anti-doping officials openly, nowadays they don’t fear to announce about this aspect.